Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
184B5
NM
Basal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
5897.085
uM
1.52970
2.52550
-0.9132 -0.8317 1.9539 0.6859
0.9971
1.2392
184B5
NM
Basal
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
5896.067
uM
4.54790
8.20140
-0.9586 -1.0000 1.8632 0.4683
0.9969
1.4536
184B5
NM
Basal
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
5897.067
uM
7.12490
9.50480
-0.9660 -0.9702 3.7422 0.4265
0.9982
1.1908
184B5
NM
Basal
TAPI-0
TACE/Collagenase
5897.096
uM
inf
992.95260
0.8920 0.4929 0.4192 0.0203
0.7286
1.2810
184B5
NM
Basal
Taxol
TUBB
TUBB
12979.002
uM
inf
0.00871
0.5987 0.6417 4.9974 0.2293
0.6910
1.3178
184B5
NM
Basal
Taxol
TUBB
TUBB
9095.002
uM
0.01783
0.01144
-0.0925 0.1784 0.9939 0.4787
0.9002
1.0607
184B5
NM
Basal
TCS 2312
CHK1
CHK
12566.152
uM
0.47856
0.67095
-0.6926 -0.4982 2.0460 0.4394
0.9768
1.4827
184B5
NM
Basal
TCS PIM-1 1
Pim kinase
PIM
12566.135
uM
2.28850
2.41580
-0.0883 -0.0683 2.3643 0.3297
0.9954
1.6384
184B5
NM
Basal
Temsirolimus
MTOR
MTOR
12566.168
uM
31.79770
47.19180
-0.9110 -1.0000 2.7825 0.3358
0.8544
1.4366
184B5
NM
Basal
Topotecan
TOP1
TOP
9095.121
uM
0.07632
0.71426
-0.8323 -1.0000 0.4913 0.8207
0.9828
1.1992
184B5
NM
Basal
Tozasertib
AURK/FLT3/ABL/JAK2
AURK
12566.169
uM
2.34370
11.34480
-0.7494 -1.0000 0.6966 0.3916
0.9813
1.6359
184B5
NM
Basal
TPCA-1
IKK
NFKB
5897.093
uM
13.34050
4.19070
0.4757 0.4767 2.6493 0.0943
0.9817
1.2047
184B5
NM
Basal
Trastuzumab
HER2
ErbB
9095.026
uM
inf
6.71320
0.7144 0.5130 4.9565 -0.0290
0.80
1.0168
184B5
NM
Basal
Trichostatin A
HDAC
HDAC
5897.065
uM
88.76350
175.5770
-0.9241 -0.9748 1.5858 0.5421
0.9958
1.2996
184B5
NM
Basal
Trichostatin A
HDAC
HDAC
5896.065
uM
26.14030
64.67810
-0.8868 -0.9295 1.1596 0.6633
0.9990
1.4978
184B5
NM
Basal
Triciribine
AKT
AKT
5897.074
uM
0.14593
0.26720
-0.6810 -0.6218 1.3360 0.6294
0.9925
1.2824
184B5
NM
Basal
Triciribine
AKT
AKT
5896.074
uM
0.08583
0.37083
-0.6648 -0.7348 0.6178 0.6095
0.9963
1.4124
184B5
NM
Basal
Valproic acid
HDAC
HDAC
12566.143
uM
826.74090
1000.00000
0.0037 -0.0768 0.7513 0.2545
0.9630
1.6413
184B5
NM
Basal
Vorinostat
HDAC
HDAC
5896.065
uM
114.54920
884.06290
-0.8093 -1.0000 0.5376 0.5272
0.9847
1.4978
184B5
NM
Basal
Vorinostat
HDAC
HDAC
5897.065
uM
217.22220
1000.00000
-0.7078 -0.8643 0.6574 0.4634
0.9850
1.2996
184B5
NM
Basal
XRP44X
ELK3
MAPK
12566.171
uM
0.34734
0.19490
0.1674 0.1823 0.7846 0.4183
0.9903
1.5151
184B5
NM
Basal
ZM-447439
AURK
AURK
12566.169
uM
inf
0.69572
0.6262 0.6434 1.3748 0.1369
0.9197
1.6359
21MT-1
HER2amp
-
Bortezomib
Proteasome
Proteasome
14779.203
uM
2.22370
3.73670
-0.7373 -0.7957 1.8347 0.4364
0.9894
1.9695
21MT-1
HER2amp
-
Bortezomib
Proteasome
Proteasome
14779.203
uM
2.22370
3.73670
-0.7373 -0.7957 1.8347 0.4364
0.9894
1.9695
21MT-1
HER2amp
-
Dichloroacetate
PDK
PDK
13719.176
uM
inf
inf
0.9233 0.9233 0.0000 0.0596
-0.2426
0.8672